Canada markets closed

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.93+0.06 (+0.87%)
At close: 03:41PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 39.91M
Enterprise Value 23.61M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.78
Price/Book (mrq)2.69
Enterprise Value/Revenue 5.44
Enterprise Value/EBITDA -1.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52-Week Change 3-37.51%
S&P500 52-Week Change 322.93%
52 Week High 335.00
52 Week Low 36.65
50-Day Moving Average 38.11
200-Day Moving Average 39.60

Share Statistics

Avg Vol (3 month) 32.06k
Avg Vol (10 day) 33.27k
Shares Outstanding 55.69M
Implied Shares Outstanding 6N/A
Float 82.36M
% Held by Insiders 10.00%
% Held by Institutions 18.94%
Shares Short (Nov. 14, 2021) 41.52k
Short Ratio (Nov. 14, 2021) 41.06
Short % of Float (Nov. 14, 2021) 4N/A
Short % of Shares Outstanding (Nov. 14, 2021) 40.03%
Shares Short (prior month Oct. 14, 2021) 4902

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin -281.08%
Operating Margin (ttm)-282.40%

Management Effectiveness

Return on Assets (ttm)-43.47%
Return on Equity (ttm)-89.76%

Income Statement

Revenue (ttm)4.64M
Revenue Per Share (ttm)0.87
Quarterly Revenue Growth (yoy)638.20%
Gross Profit (ttm)-6.47M
EBITDA -13.37M
Net Income Avi to Common (ttm)-13.05M
Diluted EPS (ttm)-2.66
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.49M
Total Cash Per Share (mrq)2.72
Total Debt (mrq)521.22k
Total Debt/Equity (mrq)3.91
Current Ratio (mrq)5.33
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)-11.06M
Levered Free Cash Flow (ttm)-6.19M